Last week, under a rarely used procedure known as a discharge motion, the House of Representatives passed a three-year extension of the enhanced Affordable Care Act (ACA) healthcare tax credit, which expired on December 31.
Congress considered but ultimately declined to enact legislation mandating that pharmacy benefit managers (PBMs) operate in a prescribed financial arrangement with their customers.
Yesterday, the Food and Drug Administration (FDA) announced long-overdue reforms to the biosimilar approval process that will boost biosimilar development and competition in the United States.
Today, MGA released a report in collaboration with the HDA measuring the economic impact of healthcare distributors in the United States.
Following the release of the new MGA white paper “The Long-Term Effects of Medicare Price Negotiations on Drug Competition,” Alex Brill spoke with Stanton Mehr at Biosimilars Review & Report.
